dc.contributor.author
Canals, Albert
dc.contributor.author
Arribas Bosacoma, Raquel
dc.contributor.author
Albericio Palomera, Fernando
dc.contributor.author
Álvarez Domingo, Mercedes
dc.contributor.author
Aymamí, Joan
dc.contributor.author
Coll, Miquel
dc.date.issued
2019-03-29T13:30:24Z
dc.date.issued
2019-03-29T13:30:24Z
dc.date.issued
2017-01-04
dc.date.issued
2019-03-29T13:30:24Z
dc.identifier
https://hdl.handle.net/2445/131078
dc.description.abstract
Variolin B is a rare marine alkaloid that showed promising anti-cancer activity soon after its isolation. It acts as a cyclin-dependent kinase inhibitor, although the precise mechanism through which it exerts the cytotoxic effects is still unknown. The crystal structure of a variolin B bound to a DNA forming a pseudo-Holliday junction shows that this compound can also contribute, through intercalative binding, to either the formation or stabilization of multi-stranded DNA forms.
dc.format
application/pdf
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/srep39680
dc.relation
Scientific Reports, 2017, vol. 7, num. 39680
dc.relation
https://doi.org/10.1038/srep39680
dc.rights
cc-by (c) Canals, Albert et al., 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Medicaments antineoplàstics
dc.subject
Medicaments antivírics
dc.subject
Antineoplastic agents
dc.subject
Antiviral agents
dc.title
Intercalative DNA binding of the marine anticancer drug variolin B
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion